Decreased respiratory symptoms in cannabis users who vaporize

被引：75

作者：

Earleywine M. ^{[1
]}

Barnwell S.S. ^{[2
]}

机构：

[1] Department of Psychology, University at Albany, State University of New York, Albany, NY 12222

[2] Department of Psychology, University of Southern California, Los Angeles

来源：

Harm Reduction Journal | / 4卷 / 1期

关键词：

Respiratory Symptom; Methamphetamine; Respiratory Problem; Cannabis User; Regular User;

D O I：

10.1186/1477-7517-4-11

中图分类号：

学科分类号：

摘要：

Cannabis smoking can create respiratory problems. Vaporizers heat cannabis to release active cannabinoids, but remain cool enough to avoid the smoke and toxins associated with combustion. Vaporized cannabis should create fewer respiratory symptoms than smoked cannabis. We examined self-reported respiratory symptoms in participants who ranged in cigarette and cannabis use. Data from a large Internet sample revealed that the use of a vaporizer predicted fewer respiratory symptoms even when age, sex, cigarette smoking, and amount of cannabis used were taken into account. Age, sex, cigarettes, and amount of cannabis also had significant effects. The number of cigarettes smoked and amount of cannabis used interacted to create worse respiratory problems. A significant interaction revealed that the impact of a vaporizer was larger as the amount of cannabis used increased. These data suggest that the safety of cannabis can increase with the use of a vaporizer. Regular users of joints, blunts, pipes, and water pipes might decrease respiratory symptoms by switching to a vaporizer. © 2007 Earleywine and Barnwell; licensee BioMed Central Ltd.

引用

共 14 条

[1]

Tashkin D.P., Baldwin G.C., Sarafian T., Dubinett S., Roth M.D., Respiratory and immunologic consequences of marijuana smoking, J Clin Pharmacol, 42, SUPPL. 11, (2002)

[2]

Melamede R., Cannabis and tobacco smoke are not equally carcinogenic, Harm Reduction Journal, 2, (2005)

[3]

Gieringer D., St Laurent J., Goodrich S., Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds, Journal of Cannabis Therapeutics, 4, pp. 7-27, (2004)

[4]

Hazekamp A., Ruhaak R., Zuurman L., van Gerven J., Verpoorte R., Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol, J Pharm Sci, 95, pp. 1308-1317, (2006)

[5]

Okie S., Medical marijuana and the Supreme Court, NEJM, 353, pp. 648-651, (2005)

[6]

Taylor D.R., Poulton R., Moffitt T.E., Ramankutty P., Sears M.R., The respiratory effects of cannabis dependence in young adults, Addiction, 95, pp. 1669-1677, (2000)

[7]

Barnwell S.S., Earleywine M., Wilcox R., Cannabis, motivation, and life satisfaction in an internet sample, Subst Abuse Treat Prev Policy, 1, (2006)

[8]

Reinarman C., Cohen P.D.A., Kaal H.L., The limited relevance of drug policy: Cannabis in Amsterdam and in San Francisco, Am J Public Health, 94, pp. 836-842, (2004)

[9]

Aiken L., West S., Multiple Regression: Testing and Interpreting Interactions, (1991)

[10]

Wang Y.C., Lee C.M., Lew-Ting C.Y., Hsiao C.K., Chen D.R., Chen W.J., Survey of substance use among high school students in Taipei: Web-based questionnaire versus paper-and-pencil questionnaire, J Adolesc Health, 37, pp. 289-295, (2005)

← 1 2 →